Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres

Published:2016-12-21 Issue:1 Volume:112 Page:9-17
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

van der Meer P. F.¹²,Couture C.³,Hervig T.⁴,Kruit G.⁵,Devine D. V.³,de Korte D.¹,Kerkhoffs J.-L.²⁶

Affiliation:

1. Department of Product and Process Development; Sanquin Blood Bank; Amsterdam The Netherlands

2. Department of Clinical Transfusion Research; Sanquin Research; Leiden The Netherlands

3. Canadian Blood Services; Ottawa ON Canada

4. Department of Immunology and Transfusion Medicine; Haukeland University Hospital; Bergen Norway

5. Department of Production; Sanquin Blood Bank; Amsterdam The Netherlands

6. Department of Hematology; Haga Teaching Hospital; The Hague The Netherlands

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/vox.12465/fullpdf

Reference19 articles.

1. A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns;Goodrich;Transfusion,2009

2. Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants;Asano;Transplantation,2007

3. Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice;Jackman;Transfusion,2013

4. The use of riboflavin for the inactivation of pathogens in blood products;Goodrich;Vox Sang,2000

5. A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology;Mirasol Clinical Evaluation Study Group;Transfusion,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remodelling whole blood processing through automation and pathogen reduction technology at the Luxembourg Red Cross;Transfusion and Apheresis Science;2021-10

2. Haemostatic function measured by thromboelastography and metabolic activity of platelets treated with riboflavin and UV light;BLOOD TRANSFUS-ITALY;2020

3. Use and safety of riboflavin and UV light‐treated platelet transfusions in children over a five‐year period: focusing on neonates;Transfusion;2019-10-06

4. The role of pathogen‐reduced platelet transfusions on HLA alloimmunization in hemato‐oncological patients;Transfusion;2018-11-30

5. Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system;BLOOD TRANSFUS-ITALY;2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3